Global Orlistat Market was valued at USD 3.02 billion in 2021 and is expected to reach USD 4.61 billion by the year 2028, at a CAGR of 6.2%.
Orlistat is a drug designed to treat obesity. Primary function of Orlistat is to prevent absorption of fat from the diet consumed by humans. It prevents absorption of fats by acting as lipase inhibitors, which eventually reduce the calorie intake....
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian